Recently Dr. Ron Levy had a breakthrough publication in Science Translational Medicine showing that a combination of two immunotherapy drugs given as a vaccine can eradicate or prevent the occurrence of multiple types of cancers in mice. He is about to open a corresponding Phase I study for non-Hodgkin lymphoma patients. This publication has gotten a lot of media attention and as a result, many interested individuals have reached out hoping to be part of this study.
A landing page with information has been created at: http://cancer.stanford.edu/trials/vaccine.html. If you happen to be contacted, please refer to this webpage.